Literature DB >> 26206270

Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.

Julie Medina1, Houda Boukhebza2, Amélie De Saint Jean3, Régis Sodoyer4, Isabelle Legastelois5, Catherine Moste6.   

Abstract

The yield of influenza antigen production may significantly vary between vaccine strains; for example the A/California/07/09 (H1N1)-X179A vaccine virus, prepared during 2009 influenza pandemic, presented a low antigen yield in eggs compared to other seasonal H1N1 reassortants. In this study a bi-chimeric virus expressing HA and NA genes with A/Puerto Rico/8/34 (H1N1) (PR8) and X179A domains was rescued by reverse genetics using a mixture of Vero/CHOK1 cell lines (Medina et al. [7]). The bi-chimeric virus obtained demonstrated to yield much larger amounts of HA than X179A in eggs as measured by single-radial-immunodiffusion (SRID), the reference method to quantify HA protein in influenza vaccine. Such kind of optimized virus using PR8 backbone derived chimeric glycoproteins could be used as improved seed viruses for vaccine production.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chimeric; Influenza; PR8 backbone; Vaccine

Mesh:

Substances:

Year:  2015        PMID: 26206270     DOI: 10.1016/j.vaccine.2015.06.112

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

Review 1.  Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response.

Authors:  Mark B Carascal; Rance Derrick N Pavon; Windell L Rivera
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

Review 2.  New Kids on the Block: RNA-Based Influenza Virus Vaccines.

Authors:  Francesco Berlanda Scorza; Norbert Pardi
Journal:  Vaccines (Basel)       Date:  2018-04-01

3.  Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses.

Authors:  Saira Hussain; Matthew L Turnbull; Helen M Wise; Brett W Jagger; Philippa M Beard; Kristina Kovacikova; Jeffery K Taubenberger; Lonneke Vervelde; Othmar G Engelhardt; Paul Digard
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.